Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

61°
- Kane, PA (16735)
  Today
  
  Considerable cloudiness with occasional rain showers. High near 65F. Winds W at 5 to 10 mph. Chance of rain 40%. Locally heavy rainfall possible..
  
  Tonight
  
  Cloudy skies. Low 52F. Winds N at 5 to 10 mph.
  
  Updated: June 22, 2026 @ 1:59 pm
- Full Forecast

Site search

Home
News
Sports
Obituaries
Local Events
- Promote Your Event
Photos
e-Edition
Classifieds
- Place an ad
Archives
Turkey Contest
Best of 2026

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Aprea Therapeutics, Inc. - Common Stock (NQ:APRE)

0.8228 +0.0328 (+4.15%)

Streaming Delayed Price Updated: 10:48 AM EDT, Jun 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aprea Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

FDA Lifts Clinical Hold On Aprea's Relapsed/Refractory Blood Cancer Studies ↗

March 16, 2022

Aprea Therapeutics Inc (NASDAQ: APRE) can resume testing its eprenetapopt after a string of clinical holds on the therapy in August 2021. The Company plans to study the drug in new trials across...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

March 16, 2022

Stifel cut the price target on Adobe Inc. (NASDAQ: ADBE) from $700 to $600. Adobe shares rose 1.9% to $429.50 in pre-market trading.

Via Benzinga

58 Biggest Movers From Yesterday ↗

December 14, 2021

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-...

Via Benzinga

40 Stocks Moving In Monday's Mid-Day Session ↗

December 13, 2021

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction....

Via Benzinga

FDA Lifts Clinical Hold On Aprea's Eprenetapopt Trial In Myeloid Malignancies ↗

December 09, 2021

The FDA removed the full clinical hold on Aprea Therapeutics Inc's (NASDAQ: APRE) trial evaluating the combination of eprenetapopt, with acalabrutinib or...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 09, 2021

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 74.49% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More ↗

December 06, 2021

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...

Via Benzinga

You Ask, We Analyze: The Bull, Bear Case For Camber Energy And Aprea Stocks ↗

October 07, 2021

On Wednesday evening, Benzinga asked its Benzinga Pro community which tickers they’d like analyzed. From the replies Benzinga selected these two tickers for technical...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 29, 2021

Gainers Regencell Bioscience (NASDAQ:RGC)...

Via Benzinga

48 Biggest Movers From Yesterday ↗

September 29, 2021

Gainers Gogo Inc. (NASDAQ: GOGO) shares climbed 37.6% to close at $16.82 on Tuesday after the company raised the long-term financial targets announced during Q4 2020 earnings....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 21, 2021

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) stock moved upwards by 30.95% to $8.08 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...

Via Benzinga

Aprea Therapeutics Stock Jumps After Eprenetapopt Combo Data Presentation At ESMO ↗

September 21, 2021

Aprea Therapeutics Inc (NASDAQ: APRE) presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase 1/2 trial in advanced solid tumors....

Via Benzinga

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data ↗

September 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...

Via Benzinga

18 Stocks Moving in Tuesday's Pre-Market Session ↗

September 21, 2021

Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 37% to $1.78 in pre-market trading after declining around 4% on Monday. ReWalk Robotics, last month, reported Q2 sales of $1.44...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 20, 2021

Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 22.1% to $3.37 during Monday's pre-market session. The company's market cap stands at $609.1 million....

Via Benzinga

24 Stocks Moving in Monday's Pre-Market Session ↗

September 20, 2021

Gainers Verastem, Inc. (NASDAQ: VSTM) rose 30.8% to $3.61 in pre-market trading after the company announced a mini oral presentation highlighting updated data from the ongoing...

Via Benzinga

The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight ↗

September 19, 2021

Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 20, 2021 ↗

August 20, 2021

Upgrades For Investors Bancorp Inc (NASDAQ:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2021 ↗

August 16, 2021

Upgrades For Planet Fitness Inc (NYSE:PLNT), Roth...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 13, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 13, 2021 ↗

August 13, 2021

Upgrades For ACV Auctions Inc (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 13, 2021

Gainers Biolase (NASDAQ:BIOL) stock moved upwards by 42.49% to $0.9 during Friday's pre-market session. The company's market cap stands at $135.3 million. As per...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 12, 2021

Gainers Xenetic Biosciences (NASDAQ:XBIO) shares rose 20.37% to $3.9 during Thursday's pre-market session. The company's market cap stands at $37.8 million....

Via Benzinga

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗

August 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...

Via Benzinga

Aprea Therapeutics Drops After FDA Clinical Hold On Another Blood Cancer Study ↗

August 12, 2021

After instituting a partial clinical hold on Aprea Therapeutics Inc's (NASDAQ: APRE) myeloid malignancies program, the FDA has placed a clinical hold...

Via Benzinga

Aprea Therapeutics Stock Drops On FDA Clinical Hold On Eprenetapopt Myeloid Malignancy Trials ↗

August 06, 2021

The FDA has instituted a partial clinical hold on Aprea Therapeutics Inc's (NASDAQ: APRE) clinical trials of eprenetapopt (APR-246) combined with...

Via Benzinga

Analyzing Aprea Therapeutics's Unusual Options Activity ↗

July 21, 2021

On Wednesday, shares of Aprea Therapeutics (NASDAQ:APRE) saw unusual options activity. After the option alert, the stock price moved up to $5.2. Sentiment: NEUTRAL Option Type:...

Via Benzinga

Aprea Stock Pops As Eprenetapopt Combo Regime Shows 58% Relapse-Free Survival, 79% Overall Survival At 1-Year Post-Transplant ↗

July 21, 2021

Aprea Therapeutics Inc (NASDAQ: APRE) has announced results from its Phase 2 trial evaluating eprenetapopt with azacitidine for post-transplant maintenance therapy...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 01, 2021

Gainers Alterity Therapeutics (NASDAQ:ATHE

Via Benzinga

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

The Kane Republican

KaneRepublican.com
200 North Fraley
Kane, PA 16735
Phone: 814-837-6000
Email: krnews1@zitomedia.net

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Kane, PA (16735)

Today

Tonight

Aprea Therapeutics, Inc. - Common Stock (NQ:APRE)

All News about Aprea Therapeutics, Inc. - Common Stock

Sections

Services

The Kane Republican